Browse by Divisions pre August 2011

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
[tool] Add To Shelf...
Number of items: 143.

Abu-Hilal, Mohammed, McPhail, Mark J.W., Marchand, Lucy and Johnson, Colin D. (2006) Malondialdehyde and superoxide dismutase as potential markers of severity in acute pancreatitis. Journal of the Pancreas, 7, (2), 185-92. (PMID:16525202).

Adrain, Colin, Duriez, Patrick J., Brumatti, Gabriela, Delivani, Petrina and Martin, Seamus J. (2006) The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics. Journal of Biological Chemistry, 281, (12), 8118-8125. (doi:10.1074/jbc.M509361200). (PMID:16415351).

Alexiou, C., Sheppard, S., Tang, A., Rengarajan, A., Smith, D., Haw, M. and Gibbs, R. (2006) Leukocytes-depleting filters preferentially remove activated leukocytes and reduce the expression of surface adhesion molecules during the simulated extracorporeal circulation of human blood. Asaio Journal, 52, (4), 438-444.

Andrieu, Nadine, Goldgar, David E., Easton, Douglas F., Rookus, Matti, Brohet, Richard, Antoniou, Antonis C., Peock, Susan, Evans, Gareth, Eccles, Diana, Douglas, Fiona, Nogues, Catherine, Gauthier-Villars, Marion, Chompret, Agnès, Van Leeuwen, Flora E., Kluijt, Irma, Benitez, Javier, Arver, Brita, Olah, Edith, Chang-Claude, Jenny, EMBRACE, , GENEPSO, , GEO-HEBON, and IBCCS Collaborators, (2006) Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS). Journal of the National Cancer Institute, 98, (8), 535-544. (doi:10.1093/jnci/djj132).

Appleby, Peter A. and Elliott, Terry (2006) Stable competitive dynamics emerge from multispike interactions in a stochastic model of spike-timing-dependent plasticity. Neural Computation, 18, (10), 2414-2464. (doi:10.1162/neco.2006.18.10.2414).

Babbage, Gavin, Ottensmeier, Christian H., Blaydes, Jeremy, Stevenson, Freda K. and Sahota, Surinder S. (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Research, 66, (8), 3996-4000. (doi:10.1158/0008-5472.CAN-05-3704).

Badami, Ester, Cexus, Olivier, Londei, Marco and Quaratino, Sonia (2006) The immune regulatory function of double negative T-cells in autoimmunity. Clinical Immunology, 119, (Supplement 1), p.S82. (doi:10.1016/j.clim.2006.04.129).

Badami, Ester, Cexus, Olivier, Londei, Marco and Quaratino, Sonia (2006) Naturally arising antigen-specific CD4+CD25+ regulatory T-cells fail to protect from spontaneous autoimmunity. Clinical Immunology, 119, (Supplement 1), p.S20. (doi:10.1016/j.clim.2006.04.200).

Barrett, Geraldine, Cassell, Jackie A., Peacock, Janet L. and Coleman, Michel P. (2006) National survey of British public's views on use of identifiable medical data by the National Cancer Registry. British Medical Journal (BMJ), 332, (7549), 1068-1072. (doi:10.1136/bmj.38805.473738.7C).

Barrett-Lee, P.J. and Murray, N. (2006) Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: the NCRI zice trial. Bone, 38, (3 Supplement 1), S67-S67. (doi:10.1016/j.bone.2006.01.008).

Bennouna, J., Breton, J.L., Tourani, J.M., Ottensmeier, C., O'Brien, M., Kosmidis, P., Huat, T.E., Pinel, M.C., Colin, C. and Douillard, J.Y. (2006) Vinflunine - an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study. British Journal of Cancer, 94, (10), 1383-1388. (doi:10.1038/sj.bjc.6603106).

Bergman, L. and Blaydes, J. (2006) Loss of C-terminal binding protein transcriptional corepressor leads to aberrant mitosis and cell death in breast cancer cells. Breast Cancer Research, 8, (Suppl 2), p.S4. (doi:10.1186/bcr1556).

Bergman, L.M. and Blaydes, J.P. (2006) C-terminal binding proteins: Emerging roles in cell survival and tumorigenesis. Apoptosis, 11, (6), 879-888. (doi:10.1007/s10495-006-6651-4).

Bergman, Lee M., Morris, Laila, Darley, Matthew, Mirnezami, Alexander H., Gunatilake, Samal C. and Blaydes, Jeremy P. (2006) Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins. BMC Cell Biology, 7, (35) (doi:10.1186/1471-2121-7-35).

Bhandari, Pradeep, Bateman, Adrian C., Mehta, Raj L., Stacey, Bernard S.F., Johnson, Penny, Cree, Ian A., Di Nicolantonio, Federica and Patel, Praful (2006) Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer, 6, (Article no. 134), 9pp.. (doi:10.1186/1471-2407-6-134).

Briggs, S., Goodyear, P., Thomas, R., Strike, P. and Smith, D. (2006) A national audit of the use of neuromuscular blocking drugs in cardiac anaesthesia. Anaesthesia, 61, (1), p.95. (doi:10.1111/j.1365-2044.2005.04439.x).

Broadfield, Z., Martineau, M., Moorman, A.V., Wright, S.L., Bown, N. and Harrison, C.J. (2006) PAX5-ETV6 fusion in acute lymphoblastic leukaemia does not define the dic(9;12). Journal of Medical Genetics, 43, pp.S20.

Brooks, Colin R., Elliott, Tim, Parham, Peter and Khakoo, Salim I. (2006) The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. Journal of Immunology, 176, (2), 1141-1147. (doi:10.4049/jimmunol.176.2.1141). (PMID:16434388).

Carr, James M., Carrasco, Marlene J., Thaventhiran, James E.D., Bambrough, Paul J., Kraman, Matthew, Edwards, Alexander D., Al-Shamkhani, Aymen and Fearon, Douglas T. (2006) CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation. Proceedings of the National Academy of Sciences of the United States of America, 103, (51), 19454-19459. (doi:10.1073/pnas.0609706104).

Cathomas, R., Geldart, T.R., Iveson, T., Singh, N. and Rowen, D. (2006) An unusual differential diagnosis of penile warts: metastases from rectal carcinoma. International Journal of STD & AIDS, 17, (7), 491-492. (doi:10.1258/095646206777689107).

Chapiro, Elise, Russell, Lisa, Radford-Weiss, Isabelle, Bastard, Christian, Lessard, Michel, Struski, Stephanie, Cave, Helene, Fert-Ferrer, Sandra, Barin, Carole, Maarek, Odile, Della-Valle, Veronique, Strefford, Jonathan C., Berger, Roland, Harrison, Christine J., Bernard, Olivier A. and Nguyen-Khac, Florence the Groupe Francophone de Cytogénétique Hématologique (2006) Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood, 108, (10), 3560-3563. (doi:10.1182/blood-2006-03-010835).

Cheuk, Adam T.C., Chan, Lucas, Czepulkowski, Barbara, Berger, Stuart A., Yagita, Hideo, Okumura, Ko, Farzaneh, Farzin, Mufti, Ghulam J. and Guinn, Barbara-ann (2006) Development of a whole cell vaccine for acute myeloid leukaemia. Cancer Immunology, Immunotherapy, 55, (1), 68-75. (doi:10.1007/s00262-005-0674-5).

Chicken, D.W., Kocjan, G., Falzon, M., Lee, A.C., Douek, M., Sainsbury, R. and Keshtgar, M.R.S. (2006) Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. British Journal of Surgery, 93, (5), 572-576. (doi:10.1002/bjs.5289).

Chiecchio, L., Protheroe, R.K.M., Ibrahim, A.H., Cheung, K.L., Rudduck, C., Dagrada, G.P., Cabanas, E.D., Parker, T., Nightingale, M., Wechalekar, A., Orchard, K.H., Harrison, C.J., Cross, N.C.P., Morgan, G.J. and Ross, F.M. on behalf of the UK Myeloma Forum (2006) Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia, 20, (9), 1610-1617. (doi:10.1038/sj.leu.2404304).

Copson, Ellen R., White, Helen E., Blaydes, Jeremy P., Robinson, David O., Johnson, Peter W. and Eccles, Diana M. (2006) Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers. BMC Cancer, 6, (80) (doi:10.1186/1471-2407-6-80).

Cunningham, D., Rao, S., Starling, N., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J. and Norman, A.R. (2006) Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: the REAL 2 trial. Journal of Clinical Oncology, 24, (18S), 182S-182S.

Cunningham, David, Allum, William H., Stenning, Sally P., Thompson, Jeremy N., Van de Velde, Cornelis J.H., Nicolson, Marianne, Scarffe, J. Howard, Lofts, Fiona J., Falk, Stephen J., Iveson, Timothy J., Smith, David B., Langley, Ruth E., Verma, Monica, Weeden, Simon and Chua, Yu Jo, for the MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine, 355, (1), 11-20. (doi:10.1056/NEJMoa055531).

Dachs, Gabi U., Steele, Andrew J., Coralli, Claudia, Kanthou, Chryso, Brooks, Andrew C., Gunningham, Sarah P., Currie, Margaret J., Watson, Ally I., Robinson, Bridget A. and Tozer, Gillian M. (2006) Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression. BMC cancer, 6, 280. (doi:10.1186/1471-2407-6-280). (PMID:9845117).

Davies, Andrew J. (2006) Clinical and molecular prognostic factors in follicular lymphoma. Current Oncology Reports, 8, (5), 359-367. (doi:10.1007/s11912-006-0059-8).

Davies, Jeffrey K., Taussig, David C., Oakervee, Heather, Davies, Andrew J., Agrawal, Samir G., Gribben, John G., Lister, T. Andrew and Cavenagh, Jamie D. (2006) Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myeloidsplastic syndrome: late CNS relapses despite graft-versus-host disease. American Society of Clinical Oncology, 24, (14), e23-e25. (doi:10.1200/JCO.2006.05.7281).

Delivani, Petrina, Adrain, Colin, Taylor, Rebecca C., Duriez, Patrick J. and Martin, Seamus J. (2006) Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Molecular cell, 21, (6), 761-773. (doi:10.1016/j.molcel.2006.01.034). (PMID:16543141).

Di Genova, G., Roddick, J., McNicholl, F. and Stevenson, F.K. (2006) Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood, 107, (7), 2806-2813. (doi:10.1182/blood-2005-08-3255).

Di Genova, Gianfranco, Roddick, Joanna, McNicholl, Feargal and Stevenson, Freda K. (2006) Vaccination of human subjects expands both specific and bystander memory T cells, but antibody production remains vaccine-specific. Blood, 107, (7), 2806-2813. (doi:10.1182/blood-2005-08-3255).

Doores, Katie J., Mimura, Yusuke, Dwek, Raymond A., Rudd, Pauline M., Elliott, Tim and Davis, Benjamin G. (2006) Direct deprotected glycosyl-asparagine ligation. Chemical Communications, (13), 1401-1403. (doi:10.1039/b515472c). (PMID:16550280).

Drukier, Andrzej K., Ossetrova, Nathasha, Schors, Elena, Krasik, Galya, Grigoriev, Ivan, Koenig, Christina, Sulkowski, Miko, Holcman, Jerzy, Brown, Larry R., Tomaszewski, John E., Schnall, Mitchell D., Sainsbury, Richard, Lokshin, Anne E. and Godovac-Zimmermann, Jasminka (2006) High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics. Journal of Proteome Research, 5, (8), 1906-1915. (doi:10.1021/pr0600834).

Eccles, D., Gerty, S. and Simmonds, P. (2006) High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer. Breast Cancer Research, 8, (Suppl 2), S13-S14. (doi:10.1186/bcr1582).

Elliott, T. and Neefjes, J. (2006) The complex route to MHC class I-peptide complexes. Cell, 127, (2), 249-251. (doi:10.1016/j.cell.2006.10.001).

Elliott, Tim (2006) The 'chop-and-change' of MHC class I assembly. Nature Immunology, 7, (1), 7-9. (doi:10.1038/ni0106-7). (PMID:16357848).

Eurelings, Marijke, Notermans, Nicolette C., Lokhorst, Henk M., van Kessel, Berris, Jacobs, Bart C., Wokke, John H.J., Sahota, Surinder S. and Bloem, Andries C. (2006) Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy. Journal of Neuroimmunology, 175, (1-2), 152-159. (doi:10.1016/j.jneuroim.2006.02.008).

Fitzsimmons, D., Osmond, C., George, S. and Johnson, C.D. (2006) Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000: analysis by age, period and cohort. Pancreas, 33, (4), pp.461.

Flavell, David J., Warnes, Sarah L., Bryson, Christine J., Field, Sarah A., Noss, Armorel L., Packham, Graham and Flavell, Sopsamorn U. (2006) The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. British Journal of Haematology, 134, (2), 157-170. (doi:10.1111/j.1365-2141.2006.06155.x). (PMID:16771848).

Garden, O.J., Rees, M., Poston, G.J., Mirza, D., Saunders, M., Ledermann, J., Primrose, J.N. and Parks, R. W. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut, 55, (Supplement 3), 1-8. (doi:10.1136/gut.2006.098053).

Gareth, D., Evans, R., Lalloo, F. and Eccles, D. (2006) Optimal selection of individuals for BRCA mutation testing. Journal of Clinical Oncology, 24, (20), 3311. (doi:10.1200/JCO.2006.06.6134).

Geldart, Thomas R., Gale, Joanna, McKendrick, Joe, Kirby, Julie and Mead, Graham (2006) Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU International, 98, (2), 353-358. (doi:10.1111/j.1464-410X.2006.06250.x).

Glithero, Ann, Tormo, Jose, Doering, Klaus, Kojima, Mayumi, Jones, E. Yvonne and Elliott, Tim (2006) The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate. Journal of Biological Chemistry, 281, (18), 12699-12704. (doi:10.1074/jbc.M511683200).

Glithero, Ann, Tormo, Jose, Doering, Klaus, Kojima, Mayumi, Jones, E. Yvonne and Elliott, Tim (2006) The crystal structure Of H-2Db complexed with a partial peptide epitope suggests an MHC class I assembly-intermediate. The Journal of Biological Chemistry, 281, (18), 12699-12704. (doi:10.1074/jbc.M511683200).

Gluckman, Peter D. and Hanson, Mark A. (2006) Evolution, development and timing of puberty. Trends in Endocrinology & Metabolism, 17, (1), 7-12. (doi:10.1016/j.tem.2005.11.006).

Gray, J.C., Johnson, P.W.M. and Glennie, M.J. (2006) Therapeutic potential of immunostimulatory monoclonal antibodies. Clinical Science, 111, (2), 93-106.

Gruenberger, T., Sorbye, H., Debois, M., Bethe, U., Primrose, J., Rougier, P., Jaeck, D., Finch-Jones, M., Van Cutsem, E. and Nordlinger, B. (2006) Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM). Interim results of EORTC Intergroup randomized phase III study 409837. Journal of Clinical Oncology, 24, (18s)

Guidicelli-Nicolosi, S., Rodriguez-Abreu, D., Conconi, A., Grisanti, S., Lopez-Guillermo, A., Johnson, P.W., Montserrat, E., Cavalli, F., Piffaretti, J.C. and Zucca, E. (2006) Prevalence of hepatitis C virus and GB-C virus infection among patients with B-cell non-Hodgkin's lymphoma: A case-control study of the International Extranodal Lymphoma Study Group. Annals of Oncology, 17, p.203.

Guinn, Barbara-Ann, Mohamedali, Azim, Thomas, N.Shaun B. and Mills, Ken I. (2006) Immunotherapy of myeloid leukaemias. Cancer Immunology, Immunotherapy, 56, (7), 943-957. (doi:10.1007/s00262-006-0267-y).

Guinn, Barbara-ann, Gilkes, Amanda F., Mufti, Ghulam I., Burnett, Alan K. and Mills, Ken I. (2006) The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia. British Journal of Haematology, 134, (2), 238-239. (doi:10.1111/j.1365-2141.2006.06135.x).

Hamblin, Terry (2006) Is chronic lymphocytic leukemia a response to infectious agents? Leukemia Research, 30, (9), 1063-1064. (doi:10.1016/j.leukres.2005.11.022).

Hamblin, Terry (2006) Natural products and the treatment of leukemia. Leukemia Research, 30, (6), 649-650. (doi:10.1016/j.leukres.2005.10.023).

Hamblin, Terry (2006) Prognostic factors in chronic lymphocytic leukemia. Leukemia & Lymphoma, 47, (11), 2261-2262. (doi:10.1080/10428190600947776).

Hamblin, Terry J. (2006) Autoimmune complications of chronic lymphocytic leukemia. Seminars in Oncology, 33, (2), 230-239. (doi:10.1053/j.seminoncol.2006.01.011).

Hamblin, Terry J. (2006) Conventional treatments vs. gene therapy. Scientist, 20, (7), p.15.

Hanks, Sandra, Coleman, Kim, Summersgill, Brenda, Messahel, Boo, Williamson, Dan, Pritchard-Jones, Kathryn, Strefford, Jon, Swansbury, John, Plaja, Alberto, Shipley, Janet and Rahman, Nazneen (2006) Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome. Cancer Letters, 239, (2), 234-238. (doi:10.1016/j.canlet.2005.08.006).

Hao, L., Sayers, I., Cakebread, J.A., Barton, S.J., Beghé, B., Holgate, S.T., Sampson, A.P. and Holloway, J.W. (2006) The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. Clinical & Experimental Allergy, 36, (6), 735-741. (doi:10.1111/j.1365-2222.2006.02511.x).

Harrison, Christine J., Barber, Kerry, Broadfield, Zoë, Stewart, Adam, Wright, Sarah, Martineau, Mary, Strefford, Jon C. and Moorman, Anthony V. (2006) Cytogenetic classification of T lineage acute lymphoblastic leukaemia: multiple partners of BCL11B and other novel rearrangements. Blood, 108, (11), p.584A.

Hawkins, R.E., Dangoor, A., Keilholz, U., Schadendorf, D., Harris, A., Ottensmeier, C., Smyth, J., Hoffmnan, K., Anderson, R. and Pearce, G. (2006) Phase I/II trial of a PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma. Journal of Clinical Oncology, 24, (18S), 460S-460S.

Hearle, N.C.M., Rudd, M.F., Lim, W., Murday, V., Lim, A.G., Phillips, R.K., Lee, P.W., O'Donohue, J., Morrison, P.J., Norman, A., Hodgson, S.V., Lucassen, A. and Houlston, R.S. (2006) Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. Journal of Medical Genetics, 43, (4), e15-[4pp]. (doi:10.1136/jmg.2005.036830).

Hickling, M., McCann, K., Ottensmeier, C. and Ashton-Key, M. (2006) The Immunophenotyping of primary diffuse large B-cell lymphomas of the central nervous system. Journal of Pathology, 208, (S1), 22A-22A.

Hill, K.S., Hurlock, C.A., Richardson, D., Johnson, P., Jonas, M., McKeag, N., Newman, J., Kitchker, V., Churchill, S. and Orchard, K. (2006) Indications for and outcome of transfer to the intensive care unit for haemopoietic stem cell transplant patients. Bone Marrow Transplantation, 37, (Supplement 1), pp.S181. (doi:10.1038/sj.bmt.1705324).

Hillmen, P., Richards, S., Smith, A.G., Hamblin, T.J., Milligan, D.W. and Catovsky, D. (2006) A comparison of oral and intravenous fludarabine in the LRF CLL4 trial (on behalf of the UKNCRI CLL trials group). British Journal of Haematology, 133, (s1), p.56. (doi:10.1111/j.1365-2141.2006.06027.x).

Houssami, N. and Sainsbury, R. (2006) Breast cancer: multidisciplinary care and clinical outcomes. European Journal of Cancer, 42, (15), 2480-2491. (doi:10.1016/j.ejca.2006.05.023).

Howell, W.M. and Rose-Zerilli, M.J. (2006) Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Familial Cancer, 5, (2), 143-149. (doi:10.1007/s10689-005-0072-3).

Howse, F., Harris, S., Hedges, E., George, S., Pickering, R. and Johnson, C.D. (2006) Normal response data for the pancreatic cancer quality of life (QoL) assessment questionnaire eortc QLP-PAN26. Pancreas, 33, (4), p.469.

Ivanov, Andrei, Cragg, Mark S. and Illidge, Tim M. (2006) Treatment with the anti-CD20 antibody (B1) and irradiation result in synergistic cytotoxicity that is dependent on MAPK activation. Blood, 108, (11), p.710A.

Jardin, F., Sahota, S. S., Ruminy, P., Parmentier, F., Picquenot, J. M., Rainville, V., Buchonnet, G., Leprêtre, S., Tilly, H. and Bastard, C. (2006) Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers. Leukemia, 20, (11), 2070-2074. (doi:10.1038/sj.leu.2404370).

Johnson, C.D. (2006) Suprapubic catheterization at laparotomy. Digestive Surgery, 23, (5-6), 281-282. (doi:10.1159/000096242).

Johnson, C.D. and Fitzsimmons, D. (2006) Quality of life after surgery for chronic pancreatitis. Pancreatology, 6, (5), 497-498. (doi:10.1159/000094667).

Johnson, C.D., Roussou, P., Harris, S. and Pickering, R. (2006) Combined scaling of the responses of patients with pancreatic disease to the Eortc Qlq C30 and Qlq Pan26. Pancreas, 33, (4), p.472.

Johnson, Peter W.M., Radford, John A., Cullen, Michael H., Sydes, Matthew R., Stenning, Sally P. and Hancock, Barry W. (2006) Comparison of outcomes in studies of advanced Hodgkin's lymphoma. Journal of Clinical Oncology, 24, (20), pp.3309. (doi:10.1200/JCO.2006.06.2976).

Kalejs, Martins, Ivanov, Andrey, Plakhins, Gregory, Cragg, Mark S., Emzinsh, Dzintars, Illidge, Timothy M. and Erenpreisa, Jekaterina (2006) Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe. BMC Cancer, 6, (6) (doi:10.1186/1471-2407-6-6).

Kemp, Z., Carvajal-Carmona, L., Spain, S., Barclay, E., Gorman, M., Martin, L., Jaeger, E., Brooks, N., Bishop, D.T., Thomas, H., Tomlinson, I., Papaemmanuil, E., Webb, E., Sellick, G.S., Wood, W., Evans, G., Lucassen, A., Maher, E.R. and Houlston, R.S. (2006) Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan. Human Molecular Genetics, 15, (19), 2903-2910.

Kote-Jarai, Zsofia, Matthews, Lucy, Osorio, Ana, Shanley, Susan, Giddings, Ian, Moreews, Francois, Locke, Imogen, Evans, D. Gareth, Eccles, Diana, Williams, Richard D., Girolami, Mark, Campbell, Colin and Eeles, Ros The Carrier Clinic Collaborators (2006) Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clinical Cancer Research, 12, (13), 3896-3901.

Kuroda, Junya, Puthalakath, Hamsa, Cragg, Mark S., Kelly, Priscilla N., Bouillet, Philippe, Huang, David C.S., Kimura, Shinya, Ottmann, Oliver G., Druker, Brian J., Villunger, Andreas, Roberts, Andrew W. and Strasser, Andreas (2006) Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proceedings of the National Academy of Sciences of the USA, 103, (40), 14907-14912. (doi:10.1073/pnas.0606176103).

Lalloo, Fiona, Varley, Jennifer, Moran, Anthony, Ellis, David, O'Dair, Lindsay, Pharoah, Paul, Antoniou, Antonis, Hartley, Roger, Shenton, Andrew, Seal, Sheila, Bulman, Barbara, Howell, Anthony and Evans, D. Gareth R. (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. European Journal of Cancer, 42, (8), 1143-1150. (doi:10.1016/j.ejca.2005.11.032).

Lee, Abigail M., Clear, Andrew J., Calaminici, Maria, Davies, Andrew J., Jordan, Suzanne, MacDougall, Finlay, Matthews, Janet, Norton, Andrew J., Gribben, John G., Lister, T. Andrew and Goff, Lindsey K. (2006) Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. Journal of Clinical Oncology, 24, (31), 5052-5059. (doi:10.1200/JCO.2006.06.4642).

Lewith, George T., Thomas, Kate and Fonnebo, Vinjar (2006) Whole systems research in cancer care - Report of meeting in Tromso (Sommaroy) 14-16, September 2005. Complementary Therapies in Medicine, 14, (2), 157-164. (doi:10.1016/j.ctim.2005.11.005).

Lucassen, A. and Kaye, J. (2006) Genetic testing without consent: the implications of the new Human Tissue Act 2004. Journal of Medical Ethics, 32, (12), 690-692. (doi:10.1136/jme.2005.013631).

Lucassen, Anneke, Parker, Michael and Wheeler, Robert (2006) Ethics - Implications of data protection legislation for family history. British Medical Journal, 332, (7536), 299-301. (doi:10.1136/bmj.332.7536.299).

Lucassen, Anneke, Parker, Michael and Wheeler, Robert (2006) Implications of data protection legislation for family history. British Medical Journal, 322, (7536), 299-301. (doi:10.1136/bmj.332.7536.299).

Mant, Alexandra, Tourniaire, Guilhem, Diaz-Mochon, Juan J., Elliott, Tim J., Williams, Anthony P. and Bradley, Mark (2006) Polymer microarrays: identification of substrates for phagocytosis assays. Biomaterials, 27, (30), 5299-5306. (doi:10.1016/j.biomaterials.2006.04.040). (PMID:16808972).

McCann, K.J., Johnson, P.W., Stevenson, F.K. and Ottensmeier, C.H. (2006) Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event? Leukemia, 20, (3), 530-534. (doi:10.1038/sj.leu.2404095).

McWhirter, John R., Kretz-Rommel, Anke, Saven, Alan, Maruyama, Toshiaki, Potter, Kathleen N., Mockridge, C. Ian, Ravey, E. Prenn, Qin, Fenghua and Bowdish, Katherine S. (2006) Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proceedings of the National Academy of Sciences of the United States of America, 103, (4), 1041-1046. (doi:10.1073/pnas.0510081103).

Mcphail, M.J.W., Bu-Hilal, M. and Johnson, C.D. (2006) A meta-analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery. British Journal of Surgery, 93, (9), 1038-1044. (doi:10.1002/bjs.5424).

Mead, G.M., Rustin, G.J., Stenning, S.P., Vasey, P., Aass, N., Huddart, R., Sokal, M. and Kirk, S. (2006) Medical Research Council trial of 2 versus 5 CT scans in the surveillance of patients with stage I non-seminomatous germ cell tumours of the testis. Journal of Clinical Oncology, 24, (18), 4519.

Meyer, S., Barber, L.M., White, D.J., Will, A.M., Birch, J. M., Kohler, J.A., Ersfeld, K., Blom, E., Joenje, H., Eden, T.O.B. and Taylor, G.M. (2006) Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. British Journal of Haematology, 133, (3), 284-292.

Michels, J., Foria, V., Mead, B., Jackson, G., Mullee, M., Johnson, P.W. and Packham, G. (2006) Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma. British Journal of Haematology, 132, (6), 743-746. (doi:10.1111/j.1365-2141.2005.05954.x).

Michels, J., Geldart, T., Darby, A., Craddock, L., Iveson, A., Richardson, L. and Iveson, T. (2006) The combination of raltitrexed (Tomudex) and mitomycin-C in the treatment of advanced colorectal cancer - A phase II study. Clinical Oncology, 18, (6), 431-435. (doi:10.1016/j.clon.2006.01.003).

Mitchell, Gillian, Antoniou, Antonis C., Warren, Ruth, Peock, Susan, Brown, Judith, Davies, Russell, Mattison, Jenny, Cook, Margaret, Warsi, Iqbal, Evans, D. Gareth, Eccles, Diana, Douglas, Fiona, Paterson, Joan, Hodgson, Shirley, Izatt, Louise, Cole, Trevor, Burgess, Lucy, Eeles, Ros and Easton, Douglas F. (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Research, 66, (3), 1866-1872.

Mitrou, Panagiota N., Watson, Mark A., Loktionov, Alexandre S., Cardwell, Christopher, Gunter, Marc J., Atkin, Wendy S., Macklin, Christopher P., Cecil, Tom, Bishop, Timothy D., Primrose, John and Bingham, Sheila A. (2006) MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom). Cancer Causes & Control, 17, (6), 793-801. (doi:10.1007/s10552-006-0016-8).

Nolan, L., Chilton, S., Lorigan, P., Else, R., Smith, P., Sweetenham, J. W. and Johnson, P. W. (2006) Randomised, placebo-controlled, trial comparing low dose versus standard dose Lenograstim (L) following myeloablative chemotherapy (HDT) and peripheral blood progenitor cell rescue [PBPCR) for lymphoma. Journal of Clinical Oncology, 24, (18S), 452S-452S.

Nystrom, Maria L., McCullough, Diana, Weinreb, Paul H., Violette, Shelia M., Speight, Paul M., Marshall, John F., Hart, Ian R. and Thomas, Gareth J. (2006) Cyclooxygenase-2 Inhibition suppresses ?vß6 integrin–dependent oral squamous carcinoma invasion. Cancer Research, 66, (22), 10833-10842. (doi:10.1158/0008-5472.CAN-06-1640).

Oh, K., Khan, S.G., Imoto, K., Jaspers, N., Raams, A., Ueda, T., Lehmann, A., Friedmann, P., Emmert, S., Gratchev, A., Lachlan, K., Lucassan, A. and Kraemer, K.H. (2006) Sequential assembly of nucleotide excision repair factors at sites of DNA damage in XP-B cells. Journal of Investigative Dermatology, 126, (Supplement 4s), p.78.

Orchard, K.H., Cooper, M., Lewington, V., Tristam, M., Zivanovic, M., Thom, J., Quadri, S., Richardson, D., Causer, L. and Johnson, P. (2006) Targeted radiotherapy in haematopoietic stem cell transplantation: results of a phase I trial using an Yttrium-90-labelled anti-CD66 murine monoclonal antibody demonstrating consistent BM targeting. Bone Marrow Transplantation, 37, (Supplement 1), S45-S46. (doi:10.1038/sj.bmt.1705323).

Orchard, K.H., Cooper, M., Lewington, V., Tristam, M., Zivanovic, M., Thom, J., Quadri, S., Richardson, D., Causer, L. and Johnson, P. (2006) Targeted radiotherapy in the conditioning prior to haematopoietic stem cell transplantation: Results of a phase I trial using an yttrium-90-labelled anti-CD66 murine monoclonal antibody demonstrating consistently high BM uptake. Biology of Blood and Marrow Transplantation, 12, (2), 10-11. (doi:10.1016/j.bbmt.2005.11.036).

Pearce, C. B., Gonzalez-Gonzalez, J. A., Garcia-Cantu, D. A., Gunn, S. R. and Johnson, C. D. (2006) Evaluation on a Mexican cohort of a UK computer model developed to predict severity of acute pancreatitis. Gut, 55, (Supplement 2), A49-A49.

Pearce, Callum B., Gunn, Steve R., Ahmed, Adil and Johnson, Colin D. (2006) Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein. Pancreatology, 6, (1-2), 123-131. (doi:10.1159/10.1159/000090032).

Phillips, A., Darley, M. and Blaydes, J.P. (2006) GC-selective DNA-binding antibiotic, Mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis. Oncogene, 25, (30), 4183-4193. (doi:10.1038/sj.onc.1209451).

Phillips, Anna, Jones, Chris J. and Blaydes, Jeremy P. (2006) The mechanisms of regulation of Hdm2 protein level by serum growth factors. FEBS Letters, 580, (1), 300-304. (doi:10.1016/j.febslet.2005.12.026).

Poole, Christopher J., Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, Sarah, Grieve, Robert J., Spooner, David A., Agrawal, Rajiv K., Fernando, Indrajit N., Brunt, A. Murray, O'Reilly, Susan M., Crawford, S. Michael, Rea, Daniel W., Simmonds, Peter, Mansi, Janine L., Stanley, Andrew, Harvey, Peter, McAdam, Karen, Foster, Liz, Leonard, Robert C.F. and Twelves, Christopher J., for the NEAT Investigators and the SCTBG (2006) Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. New England Journal of Medicine, 355, (18), 1851-1862. (doi:10.1056/NEJMoa052084).

Potter, Kathleen N., Mockridge, C. Ian, Neville, Louise, Wheatley, Isla, Schenk, Michael, Orchard, Jennifer, Duncombe, Andrew S., Packham, Graham and Stevenson, Freda K. (2006) Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia. Clinical Cancer Research, 12, (6), 1672-1679. (doi:10.1158/1078-0432.CCR-05-2164).

Price, Sarah, Lewith, George and Thomas, Kate (2006) Acupuncture care for breast cancer patients during chemotherapy: A feasibility study. Integrative Cancer Therapies, 5, (4), 308-314. (doi:10.1177/1534735406294899).

Quintero, Marisol, Brennan, Peter A., Thomas, Gareth J. and Moncada, Salvador (2006) Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1? in cancer: role of free radical formation. Cancer Research, 66, (2), 770-774. (doi:10.1158/0008-5472.CAN-05-0333).

Radcliffe, Joanna N., Roddick, Joanne S., Friedmann, Peter S., Stevenson, Freda K. and Thirdborough, Stephen M. (2006) Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8(+) T cells. Journal of Immunology, 177, (10), 6626-6633.

Radcliffe, Joanna N., Roddick, Joanne S., Friedmann, Peter S., Stevenson, Freda K. and Thirdborough, Stephen M. (2006) Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells. Journal of Immunology, 177, (10), 6626-6633.

Rajagopal, Ambil S., Copson, Ellen, Addis, Bruce, Shinkfield, Mark and Mead, Graham (2006) Plasmablastic lymphoma: a case of rectal disease with spinal cord compression. Leukemia & Lymphoma, 47, (12), 2670-2673. (doi:10.1080/10428190600909727).

Reni, M., Bonetto, E., Cordio, S., Passoni, P., Milandri, C., Cereda, S., Spreafico, A., Galli, L., Bordonaro, R., Staudacher, C., Di Carlo, V. and Johnson, C.D. (2006) Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III Randomized trial. Pancreatology, 6, (5), 454-463. (doi:10.1159/000094563).

Renwick, Anthony, Thompson, Deborah, Seal, Sheila, Kelly, Patrick, Chagtai, Tasnim, Ahmed, Munaza, North, Bernard, Jayatilake, Hiran, Barfoot, Rita, Spanova, Katarina, McGuffog, Lesley, Evans, D. Gareth, Eccles, Diana, Easton, Douglas F., Stratton, Michael R. and Rahman, Nazneen Breast Cancer Susceptibility Collaboration (UK) (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genetics, 38, (8), 873-875. (doi:10.1038/ng1837).

Rice, Jason, Dunn, Stuart, Piper, Karen, Buchan, Sarah L., Moss, Paul A. and Stevenson, Freda K. (2006) DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Cancer Research, 66, (10), 5436-5442. (doi:10.1158/0008-5472.CAN-05-3130).

Richardson, D., Hodges, E., Mani, A., Hurlock, C., Newman, J., McKeag, N., Kitchker, V., Williams, A. and Orchard, K. (2006) B-lymphocyte reconstitution following allogeneic stem cell transplantation for haematological disorders. Bone Marrow Transplantation, 37, (Supplement 1), S155-S156. (doi:10.1038/sj.bmt.1705324).

Roberts, Kathryn A., Martineau, Mary, Broadfield, Zoe J., Gibson, Brenda E.S., Harewood, Louise, Stewart, Janet and Harrison, Christine J. (2006) A diminutive chromosome 21 centromere in acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 167, (1), 78-81. (doi:10.1016/j.cancergencyto.2005.10.010).

Robertson, R., Campbell, C., Weller, D.P., Elton, R., Mant, D., Primrose, J., Nugent, K., Macleod, U. and Sharma, R. (2006) Predicting colorectal cancer risk in patients with rectal bleeding. British Journal of General Practice, 56, (531), 763-767.

Rutherford, E.E., Ferguson, J.L., Geldart, T.R., Mead, G.M., Smart, J.M. and Tung, K.T. (2006) Late relapse of metastatic non-seminomatous testicular germ cell tumours. Clinical Radiology, 61, (11), 907-915.

Sahota, Surinder S., Goonewardena, C. Madusha, Cooper, Christopher D.O., Liggins, Amanda P., Ait-Tahar, Kamal, Zojer, Niklas, Stevenson, Freda K., Banham, Alison H. and Pulford, Karen (2006) Correspondence to the editor: PASD1 is a potential multiple myeloma-associated antigen. Blood, 108, (12), 3953-3955.

Sahota, Surinder Singh and Stevenson, Freda K. (2006) Lineage complexity in multiple myeloma? Leukemia & Lymphoma, 47, (9), 1997-1998. (doi:10.1080/10428190600758686).

Sanderson, R.N., Johnson, P.R., Moorman, A.V., Roman, E., Willett, E., Taylor, P.R., Proctor, S.J., Bown, N., Ogston, S. and Bowen, D.T. (2006) Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia. Leukemia, 20, (3), 444-450. (doi:10.1038/sj.leu.2404055).

Santos, Susana G., Antoniou, Antony N., Sampaio, Paula, Powis, Simon J. and Arosa, Fernando A. (2006) Lack of tyrosine 320 impairs spontaneous endocytosis and enhances release of HLA-B27 molecules. Journal of Immunology, 176, (5), 2942-2949.

Saunders, M. and Iveson, T. (2006) Management of advanced colorectal cancer: state of the art. British Journal of Cancer, 95, (2), 131-138. (doi:10.1038/sj.bjc.6603233).

Savelyeva, N. and Stevenson, F.K. (2006) Vulnerability of a vaccine-induced anti-tumor B-cell response to soluble protein antigen in the absence of T cell help. Journal of Immunology, 176, S253-S254.

Schirmbeck, Reinhold, Riedl, Petra, Kupferschmitt, Mark, Wegenka, Ursula, Hauser, Hansjörg, Rice, Jason, Kroger, Andrea and Reimann, Jörg (2006) Priming protective CD8 T cell immunity by DNA vaccines encoding chimeric, stress protein-capturing tumor-associated antigen. Journal of Immunology, 177, (3), 1534-1542.

Seal, Sheila, Thompson, Deborah, Renwick, Anthony, Elliott, Anna, Kelly, Patrick, Barfoot, Rita, Chagtai, Tasnim, Jayatilake, Hiran, Ahmed, Munaza, Spanova, Katarina, North, Bernard, McGuffog, Lesley, Evans, D. Gareth, Eccles, Diana, Easton, Douglas F., Stratton, Michael R. and Rahman, Nazneen (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nature Genetics, 38, (11), 1239-1241. (doi:10.1038/ng1902).

Seedhouse, Claire H., Grundy, Martin, White, Paul, Li, Yun, Fisher, Janet, Yakunina, Darya, Moorman, Anthony, Russell, Nigel, Burnett, Alan and Pallis, Monica (2006) Competing influences of genetic and leukaemia-specific factors on P-glycoprotein expression in blasts from 817 patients entered into the NCRN AML14 and 15 trials. Blood (ASH Annual Meeting Abstracts), 108, (11), 251A-251A.

Shanley, Susan, McReynolds, Kate, Rdern-Jones, Audrey, Ahern, Roger, Fernando, Indrajit, Yarnold, John, Evans, Gareth, Eccles, Diana, Hodgson, Shirley, Ashley, Sue, Ashcroft, Linda, Tutt, Andrew, Bancroft, Elizabeth, Short, Susan, Gui, Gerald, Barr, Lester, Baildam, Andrew, Howell, Anthony, Royle, Gavin, Pierce, Lori, Easton, Douglas and Eeles, Rosalind The Breast Unit of the Royal Marsden NHS Foundation Trust (2006) Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research, 12, (23), 7025-7032.

Shanley, Susan, McReynolds, Kate, Rdern-Jones, Audrey, Ahern, Roger, Fernando, Indrajit, Yarnold, John, Evans, Gareth, Eccles, Diana, Hodgson, Shirley, Ashley, Sue, Ashcroft, Linda, Tutt, Andrew, Bancroft, Elizabeth, Short, Susan, Smith, Ian, Gui, Gerald, Barr, Lester, Baildam, Andrew, Howell, Anthony, Royle, Gavin, Pierce, Lori, Easton, Douglas and Eeles, Rosalind The Breast Unit of the Royal Marsden NHS Foundation Trust (2006) Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clinical Cancer Research, 12, (23), 7033-7038.

Simmonds, P.C., Primrose, J.N., Colquitt, J.L., Garden, O.J., Poston, G.J. and Rees, M. (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. British Journal of Cancer, 94, (7), 982-999. (doi:10.1038/sj.bjc.6603033).

Smith, Paula, McGuffog, Lesley, Easton, Douglas F., Mann, Graham J., Pupo, Gulietta M., Newman, Beth, Chenevix-Trench, Georgia, Szabo, Csilla, Southey, Melissa, Renard, Hélène, Odefrey, Fabrice, Lynch, Henry, Stoppa-Lyonnet, Dominique, Couch, Fergus, Hopper, John L., Giles, Graham G., McCredie, Margaret R.E., Buys, Saundra, Andrulis, Irene, Senie, Ruby, Goldgar, David E., Oldenburg, Rogier, Kroeze-Jansema, Karin, Kraan, Jaennelle, Meijers-Heijboer, Hanne, Klijn, Jan G.M., van Asperen, Christi, van Leeuwen, Inge, Vasen, Hans F.A., Cornelisse, Cees J., Devilee, Peter, Baskcomb, Linda, Seal, Sheila, Barfoot, Rita, Mangion, Jon, Hall, Anita, Edkins, Sarah, Rapley, Elizabeth, Wooster, Richard, Chang-Claude, Jenny, Eccles, Diana, Evans, D. Gareth, Futreal, P. Andrew, Nathanson, Katherine L., Weber, Barbara L., Rahman, Nazneen and Stratton, Michael R. (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes, Chromosomes and Cancer, 45, (7), 646-655. (doi:10.1002/gcc.20330).

Steele, A.J., Jones, D.T., Ganeshaguru, K., Duke, V.M., Yogashangary, B.C., North, J.M., Lowdell, M.W., Kottaridis, P.D., Mehta, A., Prentice, A.G., Hoffbrand, A.V. and Wickremasinghe, R.G. (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia, 20, (6), 1073-1079. (doi:10.1038/sj.leu.2404230). (PMID:16628188).

Stevenson, Freda K. and Rice, Jason (2006) Commentary: Optimizing cancer immunotherapy trials: Back to basics. European Journal of Immunology, 36, (5), 1070-1073. (doi:10.1002/eji.200636085).

Strauss, S.J., Maharaj, L., Hoare, S., Johnson, P.W., Radford, J.A., Vinnecombe, S., Millard, L., Rohatiner, A., Boral, A., Trehu, E., Schenkein, D., Balkwill, F., Joel, S.P. and Lister, T.A. (2006) Bortezomib therapy in patients with relapsed or refractory lymphoma: Potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. Journal of Clinical Oncology, 24, (13), 2105-2112. (doi:10.1200/JCO.2005.04.6789).

Strefford, J.C., Lane, T.M., Hill, A., LeRoux, L., Foot, N.J., Shipley, J., Oliver, R.T., Lu, Y.J. and Young, B.D. (2006) Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP. Cytogenetic and Genome Research, 112, (1-2), 45-52. (doi:10.1159/000087512).

Strefford, Jon C., Worley, Helen, Barber, Kerry, Moorman, Anthony V. and Harrison, Christine J. (2006) Genome complexity in patients with acute lymphoblastic leukaemia revealed by array-based comparative genomic hybridization. Blood, 108, (11), 584A-584A.

Strefford, Jon C., van Delft, Frederick W., Robinson, Hazel M., Worley, Helen, Yiannikouris, Olga, Selzer, Rebecca, Richmond, Todd, Hann, Ian, Bellotti, Tony, Raghavan, Manoj, Young, Bryan D., Saha, Vaskar and Harrison, Christine J. (2006) Complex genomic alterations and gene expression in patients with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21. Proceedings of the National Academy of Sciences of the United States of America, 103, (21), 8167-8172. (doi:10.1073/pnas.0602360103).

Taraban, Vadim Y., Rowley, Tania F., Tough, David F. and Al-Shamkhani, Aymen (2006) Requirement for CD70 in CD4(+) Th cell-dependent and innate receptor-mediated CD8(+) T cell priming. Journal of Immunology, 177, (5), 2969-2975.

Tare, R.S., Townsend, P.A., Packham, G. and Oreffo, R.O.C. (2006) Insight into the function of Bcl-2-associated athanogene-1 anti-apoptotic protein during chondrocyte development and differentiation. Journal of Bone and Mineral Research, 21, (7), p.1150.

Teeling, Jessica L., Mackus, Wendy J. M., Wiegman, Luus J. J. M., van den Brakel, Jeroen H. N., Beers, Stephen A., French, Ruth R., van Meerten, Tom, Ebeling, Saskia, Vink, Tom, Slootstra, Jerry W., Parren, Paul W. H. I., Glennie, Martin J. and van de Winkel, Jan G. J. (2006) The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD2013. Journal of Immunology, 177, (1), 362-371.

Tilney, Henry S., Heriot, Alexander G., Purkayastha, Sanjay, Antoniou, Anthony, Aylin, Paul and Tekkis, Parris P. (2006) A national perspective on the decline of abdominoperineal resection for rectal cancer. Journal of the American College of Surgeons, 203, (3 Supplement 1), S70-S71.

Trumper, M., Ross, P.J., Cunningham, D., Norman, A.R., Hawkins, R., Seymour, M., Harper, P., Iveson, T., Nicolson, M. and Hickish, T. (2006) Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. European Journal of Cancer, 42, (7), 827-834. (doi:10.1016/j.ejca.2005.08.044).

Williams, Robin and Johnson, Paul (2006) Inclusiveness, effectiveness and intrusiveness: Issues in the developing uses of DNA profiling in support of criminal investigations. Journal of Law Medicine & Ethics, 34, (2), 234-247. (doi:10.1111/j.1748-720X.2006.00030.x).

d'Amore, Francesco, Relander, Thomas, Jerkeman, Mats, Hagberg, Hans, Osterborg, Anders, Johnson, Peter, Radford, John A., Hancock, Barry W., Gramatzki, Martin, Schmitz, Norbert, Tilly, Herve, Morschhauser, Franck, Lisby, STeen and Baadsgaard, Ole (2006) Zanolimumab, a fully human monoclonal antibody: preliminary results of an ongoing clinical trial in CD4+ peripheral T-cell lymphomas (PTCL). Blood, 108, (11), p.770A.

This list was generated on Wed Feb 22 02:26:48 2017 GMT.